Cancer Clinical Trials System Needs Comprehensive Review, NCI Director Says
NCI, Dialogue Plan A National Tissue Bank
Group Chairmen Criticize NCI Budget Priorities
Groups Point to NCI Restrictions As Source Of Problems, Discuss Prioritizing Trials
Kimes, Lenfant, To Retire
Cancer.gov Knocked Offline By Theft Of Routers
Six Centers Win Grants
PHS Plans Revitalization of Commissioned Corps
Funding Opportunities Listed (12-page issue).
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Johnson and Johnson reaches $5.5B settlement deal over talc lawsuits
- Pour a Scotch, we’re talking clinical trials and prediction markets
- FDA grants Replimune’s RP1 an accelerated approval on third submission after 10:3 vote from advisory committee
Amid political outcry, advisors accept weak data and give sponsor a chance to complete phase III trial - Consumers are increasingly accessing U.S. News rankings of cancer hospitals via AI chatbots
2026 report shows no change in the top-five lineup - The Directors: New directors Herbst and Gius chart a future built on AI, collaboration, and rural access









